Covid-19 roundup: BioN­Tech ex­ec says new pro­duc­tion sites could be added to meet de­mand — re­port; Giv­ing up on the EC, Val­ne­va looks to in­di­vid­ual coun­tries for vac­cine sup­ply deals

BioN­Tech CFO Sierk Po­et­ting says he isn’t rul­ing out the con­struc­tion of new pro­duc­tion sites to meet de­mand for its Pfiz­er-part­nered Covid-19 vac­cine.

Po­et­ting told the Han­dels­blatt news­pa­per, pub­lished in Düs­sel­dorf, Ger­many, that the com­pa­ny is in talks to ramp up ca­pac­i­ty, which could be done in six months if nec­es­sary.

“There is still room for im­prove­ment. But that will ul­ti­mate­ly al­so de­pend on de­mand,” he said, per Reuters. 

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.